Lobbying disclosures · Lobbying report
DVA: third_quarter 2026 lobbying report
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Issues related to hospice and dialysis.
Follow DVA- Became public
- Oct 20, 2026, 12:30 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 3:30 PM EST
Why this is connected
Exact legal-name match: DAVITA INC. (https://www.sec.gov/Archives/edgar/data/927066/).
Reported lobbying amounts
Income: $70,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/1f234c01-daba-4784-b0c9-9a0ea4d3e784/","filing_uuid":"1f234c01-daba-4784-b0c9-9a0ea4d3e784","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/1f234c01-daba-4784-b0c9-9a0ea4d3e784/print/","filing_document_content_type":"text/html","income":"70000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Katie Wise","dt_posted":"2026-10-20T12:30:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"975 F St NW","registrant_address_2":"Suite 550","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400693064,"url":"https://lda.gov/api/v1/registrants/400693064/","house_registrant_id":null,"name":"RED+BLUE STRATEGIES","description":"Health Care Consulting","address_1":"975 F St NW","address_2":"Suite 550","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MELANIE NATHANSON","contact_telephone":"+1 202-258-9381","dt_updated":"2026-05-30T12:28:54.268599-04:00"},"client":{"id":194277,"url":"https://lda.gov/api/v1/clients/194277/","client_id":90,"name":"DAVITA INC.","general_description":"A leading provider of dialysis services in the United States.","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-05-02"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Issues related to hospice and dialysis.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54544,"prefix":"ms","prefix_display":"MS.","first_name":"MELANIE","nickname":null,"middle_name":"JAN","last_name":"NATHANSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145382,"prefix":"ms","prefix_display":"MS.","first_name":"MEGAN","nickname":null,"middle_name":"HAUCK","last_name":"MARSHALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149686,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"KLEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151352,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"WISE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154863,"prefix":"ms","prefix_display":"MS.","first_name":"ANNABELL","nickname":null,"middle_name":"MCWHERTER","last_name":"STOKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in DVA
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Oct 7, 2025$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 7, 2025 · Joint
- Jan 17, 2024$1K–$15K
Sen. Jerry Moran (R-KS)
$1K–$15K · Traded Dec 14, 2023 · disclosed Jan 17, 2024
- Jan 17, 2024$1K–$15K
Sen. Jerry Moran (R-KS)
$1K–$15K · Traded Dec 14, 2023 · disclosed Jan 17, 2024 · Spouse
- Jan 12, 2024$1K–$15K
Sen. Tommy Tuberville (R-AL)
$1K–$15K · Traded Dec 12, 2023 · disclosed Jan 12, 2024 · Joint
- Jul 14, 2023$1K–$15K
Sen. Tommy Tuberville (R-AL)
$1K–$15K · Traded Jun 12, 2023 · disclosed Jul 14, 2023 · Joint
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.